G/A 1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease

Movement Disorders

Volumn 12, Issue 3, 1997, Pages 426-427

  Xie, T ^a   Ho, S L ^a,b   Li, L S W ^a   Ma, O C K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Catechol O methyltransferase; Parkinson's disease; Polymorphism

Indexed keywords

ADENINE; CATECHOL METHYLTRANSFERASE; GUANINE; METHIONINE; VALINE; PRIMER DNA;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME STABILITY; EXON; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; STATISTICS; THERMOSTABILITY; ALLELE; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

AGED; ALLELES; BASE SEQUENCE; CATECHOL O-METHYLTRANSFERASE; DNA PRIMERS; FEMALE; HUMANS; MALE; METHIONINE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; VALINE;

EID: 0030611325     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120325     Document Type: Article

References (7)

1. Boudikova B, Szumlanski C, Maidak B, Weinshilboum RM. Human liver catechol-O-transferase pharmacogenetics. Clin Pharmacol Ther 1990;48:381-389.
2. Bertocci B, Miggiano V, Da Prada M, et al. Human catecholO-methyltransferase: cloning and expression of the membrane associated form. Proc Natl Acad Sci USA 1991;88:1416-1420.
3. Lundstrom K, Salminen M, Jalanko A, et al. Cloning and characterization of the human placental catechoI-O-methyltransferase cDNA. DNA Cell Biol 1991;10:181-189.
4. Lotta T, Vidgren J, Tilgmann C, et al. Kinetics of human soluble and membrane-bound catechoI-O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995;34:4202-4210.
5. Tenhunen J, Salminen M, Lundstrom K, et al. Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters. Eur J Diochem 1994;223:1049-1059.
6. Rivera-Calimlim L, Reilly DK. Difference in erythrocyte catechol-O-methyltransferase activity between Orientals and Caucasians: difference in levodopa tolerance. Clin Pharmacol Ther 1984;35:804-809.
7. Woodward WR, Nutt JG. Catechol-O-methyltransferase inhibitors in the treatment of parkinsonism. In: Koller CK, Paulson G, eds. Therapy of Parkinson's disease. 2nd ed. New York: Raven Press, 1995:287-297.